Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life

Healthy Term Infants Clinical Trial

Official title:
Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life

Status Completed

Clinical Trial Summary

Growth and metabolic biomarkers of healthy term infants fed formulas with staged protein concentrations over the first year of life

Clinical Trial Description

The overall objective of this study is to assess growth and biomarkers of energy and protein metabolism in healthy term infants fed with two different study formula regimens from birth to 12 months of age and to follow up the infants to 4 years of age. ;

Study Design

Related Conditions & MeSH terms

Healthy Term Infants

Clinical Trial Details

NCT number	NCT02646969
Study type	Interventional
Source	Nestlé
Contact
Status	Completed
Phase	N/A
Start date	October 2015
Completion date	July 2022

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01137877` - Growth and Tolerance of Healthy Term Infants to a New Infant Formula	Phase 3
Completed	`NCT01155414` - Tolerance of Healthy Term Infants Fed Infant Formulas #4	Phase 3
Completed	`NCT04015050` - Randomised, Controlled Study to Assess Safety and Tolerance of Infant Formula With Prebiotics and Postbiotics in Healthy Infants.	N/A
Completed	`NCT01497314` - Growth and Safety of a Low Lactose Milk-Based Infant Formula	N/A
Terminated	`NCT02221687` - The Combiotic-Study	N/A
Completed	`NCT00712608` - The Evaluation of Cow's Milk Formula - Study B	N/A